The Mitochondrial Citrate/isocitrate Carrier Plays a Regulatory Role in Glucose-stimulated Insulin Secretion
Overview
Authors
Affiliations
Glucose-stimulated insulin secretion (GSIS) is mediated in part by glucose metabolism-driven increases in ATP/ADP ratio, but by-products of mitochondrial glucose metabolism also play an important role. Here we investigate the role of the mitochondrial citrate/isocitrate carrier (CIC) in regulation of GSIS. Inhibition of CIC activity in INS-1-derived 832/13 cells or primary rat islets by the substrate analogue 1,2,3-benzenetricarboxylate (BTC) resulted in potent inhibition of GSIS, involving both first and second phase secretion. A recombinant adenovirus containing a CIC-specific siRNA (Ad-siCIC) dose-dependently reduced CIC expression in 832/13 cells and caused parallel inhibitory effects on citrate accumulation in the cytosol. Ad-siCIC treatment did not affect glucose utilization, glucose oxidation, or ATP/ADP ratio but did inhibit glucose incorporation into fatty acids and glucose-induced increases in NADPH/NADP+ ratio relative to cells treated with a control siRNA virus (Ad-siControl). Ad-siCIC also inhibited GSIS in 832/13 cells, whereas overexpression of CIC enhanced GSIS and raised cytosolic citrate levels. In normal rat islets, Ad-siCIC treatment also suppressed CIC mRNA levels and inhibited GSIS. We conclude that export of citrate and/or isocitrate from the mitochondria to the cytosol is an important step in control of GSIS.
Metabolic and Molecular Amplification of Insulin Secretion.
Ferdaoussi M Adv Anat Embryol Cell Biol. 2024; 239:117-139.
PMID: 39283484 DOI: 10.1007/978-3-031-62232-8_5.
Molecular Targeting of the Isocitrate Dehydrogenase Pathway and the Implications for Cancer Therapy.
Ivanov S, Nano O, Hana C, Bonano-Rios A, Hussein A Int J Mol Sci. 2024; 25(13).
PMID: 39000443 PMC: 11242572. DOI: 10.3390/ijms25137337.
Cuozzo F, Viloria K, Shilleh A, Nasteska D, Frazer-Morris C, Tong J Cell Rep. 2024; 43(4):114047.
PMID: 38607916 PMC: 11164428. DOI: 10.1016/j.celrep.2024.114047.
Metabolic basis of solute carrier transporters in treatment of type 2 diabetes mellitus.
Le J, Chen Y, Yang W, Chen L, Ye J Acta Pharm Sin B. 2024; 14(2):437-454.
PMID: 38322335 PMC: 10840401. DOI: 10.1016/j.apsb.2023.09.004.
Rahul R, Stinchcombe A, Joseph J, Ingalls B IET Syst Biol. 2023; 17(6):303-315.
PMID: 37938890 PMC: 10725709. DOI: 10.1049/syb2.12077.